Daniela Freitas

543 total citations
24 papers, 368 citations indexed

About

Daniela Freitas is a scholar working on Obstetrics and Gynecology, Oncology and Reproductive Medicine. According to data from OpenAlex, Daniela Freitas has authored 24 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Obstetrics and Gynecology, 9 papers in Oncology and 6 papers in Reproductive Medicine. Recurrent topics in Daniela Freitas's work include Endometrial and Cervical Cancer Treatments (10 papers), Genetic factors in colorectal cancer (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Daniela Freitas is often cited by papers focused on Endometrial and Cervical Cancer Treatments (10 papers), Genetic factors in colorectal cancer (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Daniela Freitas collaborates with scholars based in Brazil, United States and Canada. Daniela Freitas's co-authors include Paulo M. Hoff, Maria Del Pilar Estevez-Diz, Elias Abdo Filho, Vanessa da Costa Miranda, Diogo Assed Bastos, Alexandra Matias, Scott Kopetz, Nuno Montenegro, Vanessa Costa Miranda and Â. Fêde and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Gynecologic Oncology.

In The Last Decade

Daniela Freitas

23 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Freitas Brazil 9 158 121 111 95 68 24 368
Borut Kobal Slovenia 11 156 1.0× 85 0.7× 191 1.7× 90 0.9× 99 1.5× 38 456
Maria Elena Guerrieri Italy 13 188 1.2× 128 1.1× 166 1.5× 169 1.8× 113 1.7× 27 535
Neha Kumar India 5 268 1.7× 123 1.0× 120 1.1× 98 1.0× 49 0.7× 14 423
Kohei Omatsu Japan 13 337 2.1× 126 1.0× 248 2.2× 123 1.3× 93 1.4× 61 561
G. Rangoni Italy 10 88 0.6× 69 0.6× 143 1.3× 111 1.2× 45 0.7× 26 362
Akira Yabuno Japan 11 126 0.8× 38 0.3× 123 1.1× 79 0.8× 52 0.8× 37 322
Y Minagawa Japan 11 144 0.9× 83 0.7× 117 1.1× 98 1.0× 103 1.5× 20 363
Suk Bong Koh South Korea 10 120 0.8× 79 0.7× 92 0.8× 154 1.6× 35 0.5× 29 338
Michael A. Bidus United States 12 133 0.8× 102 0.8× 177 1.6× 104 1.1× 89 1.3× 21 441
Ji-Hong Hong Taiwan 10 171 1.1× 97 0.8× 52 0.5× 74 0.8× 75 1.1× 12 360

Countries citing papers authored by Daniela Freitas

Since Specialization
Citations

This map shows the geographic impact of Daniela Freitas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Freitas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Freitas more than expected).

Fields of papers citing papers by Daniela Freitas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Freitas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Freitas. The network helps show where Daniela Freitas may publish in the future.

Co-authorship network of co-authors of Daniela Freitas

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Freitas. A scholar is included among the top collaborators of Daniela Freitas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Freitas. Daniela Freitas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freitas, Daniela, et al.. (2023). Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status. Heliyon. 9(6). e17495–e17495. 4 indexed citations
2.
Melo, Andréia Cristina de, Angélica Nogueira‐Rodrigues, Mariana Scaranti, et al.. (2023). Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil. Frontiers in Oncology. 13. 1133277–1133277. 2 indexed citations
3.
Costa, Frederico, Jack A. Tuszyński, Luciana de Carvalho, et al.. (2023). Low‐energy amplitude‐modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma. Cancer Medicine. 12(11). 12402–12412. 5 indexed citations
4.
Carvalho, Jesus Paula, et al.. (2023). Gemcitabine-Induced Radiation Recall Phenomenon in Cervical Cancer: A Case Report. Cureus. 15(5). e39228–e39228. 1 indexed citations
5.
Antón, Cristina, Daniela Freitas, Heloísa de Andrade Carvalho, et al.. (2020). Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes. PLoS ONE. 15(3). e0229543–e0229543. 7 indexed citations
6.
Bonadio, Renata Colombo, Vanessa Costa Miranda, Daniela Freitas, et al.. (2019). Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial. Journal of Clinical Oncology. 37(33). 3124–3131. 84 indexed citations
7.
8.
Harada, Guilherme, Vanessa Costa Miranda, Daniela Freitas, et al.. (2018). Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis. Journal of Global Oncology. 4(4). 1–8. 5 indexed citations
9.
Harada, Guilherme, Vanessa Costa Miranda, Patrícia Alves Ferreira, et al.. (2017). Adjuvant carboplatin and paclitaxel chemotherapy followed by radiotherapy in high-risk endometrial cancer: A retrospective analysis.. Journal of Clinical Oncology. 35(15_suppl). e17115–e17115.
10.
Freitas, Daniela, et al.. (2016). Pelvic Intravenous Leiomyomatosis – Case Report. Revista Brasileira Ginecologia e Obstetrícia. 38(8). 412–415. 6 indexed citations
11.
Miranda, Vanessa da Costa, et al.. (2016). Carboplatin-based chemoradiotherapy in advanced cervical cancer: an alternative to cisplatin-based regimen?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 201. 161–165. 15 indexed citations
12.
Miranda, Vanessa da Costa, Â. Fêde, Carlos Henrique dos Anjos, et al.. (2013). Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness. Gynecologic Oncology. 132(2). 287–291. 69 indexed citations
13.
Buzaid, Antônio C., et al.. (2011). High-dose interleukin-2 in patients with metastatic melanoma whose disease progressed after biochemotherapy. Melanoma Research. 21(4). 370–375. 2 indexed citations
14.
Hoff, Paulo M., Daniela Freitas, Yana Novis, et al.. (2010). Immune‐mediated pancytopenia induced by oxaliplatin: a case report. Transfusion. 50(7). 1453–1459. 19 indexed citations
15.
Bastos, Diogo Assed, et al.. (2010). Review: Combination therapy in high-risk stage II or stage III colon cancer: current practice and future prospects. Therapeutic Advances in Medical Oncology. 2(4). 261–272. 33 indexed citations
16.
Ferrarotto, Renata, et al.. (2010). Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature. Oncology Reviews. 4(2). 101–106. 1 indexed citations
17.
Freitas, Daniela, et al.. (2009). Medical Management of Pancreatic Adenocarcinoma. Pancreatology. 9(3). 223–232. 13 indexed citations
18.
Matias, Alexandra, et al.. (2009). Screening for twin–twin transfusion syndrome at 11–14 weeks of pregnancy: the key role of ductus venosus blood flow assessment. Ultrasound in Obstetrics and Gynecology. 35(2). 142–148. 49 indexed citations
19.
Fernandes, Gustavo dos Santos, et al.. (2009). Perioperative treatment of gastrointestinal stromal tumors.. PubMed. 23(1). 54–61. 3 indexed citations
20.
Kopetz, Scott, et al.. (2008). Adjuvant chemotherapy for stage II colon cancer.. PubMed. 22(3). 260–70; discussion 270, 273, 275. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Borut Kobal Breakdown of academic impact, for papers by Maria Elena Guerrieri Breakdown of academic impact, for papers by Neha Kumar Breakdown of academic impact, for papers by Kohei Omatsu Breakdown of academic impact, for papers by G. Rangoni Breakdown of academic impact, for papers by Akira Yabuno Breakdown of academic impact, for papers by Y Minagawa Breakdown of academic impact, for papers by Suk Bong Koh Breakdown of academic impact, for papers by Michael A. Bidus Breakdown of academic impact, for papers by Ji-Hong Hong
Rankless by CCL
2026